Prof. Dr. Michael Sticherling



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde (2022) Reich K, Augustin M, Gerdes S, Ghoreschi K, Kokolakis G, Mößner R, Mrowietz U, et al. Journal article, Review article CLASSIFICATION OF PSORIATIC ARTHRITIS, SERONEGATIVE RHEUMATOID ARTHRITIS, AND SEROPOSITIVE RHEUMATOID ARTHRITIS USING DEEP LEARNING ON MAGNETIC RESONANCE IMAGING (2022) Folle L, Bayat S, Kleyer A, Fagni F, Kapsner L, Schlereth M, Meinderink T, et al. Conference contribution, Abstract of lecture Real-world evidence from the non-interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab (2022) Gerdes S, Asadullah K, Hoffmann M, Korge B, Mortazawi D, Wegner S, Personke Y, et al. Journal article Lupus erythematosus (2022) Sticherling M, Kuhn A Authored book Advanced neural networks for classification of MRI in psoriatic arthritis, seronegative, and seropositive rheumatoid arthritis (2022) Folle L, Bayat S, Kleyer A, Fagni F, Kapsner L, Schlereth M, Meinderink T, et al. Journal article, Original article Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort (2022) Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, et al. Journal article Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry (2022) Stoelzl D, Boraczynski N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Conference contribution SCLE manifestation after mRNA COVID-19 vaccination (2022) Rechtien L, Erfurt-Berge C, Sticherling M Journal article, Letter Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) Stoelzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Journal article Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. (2022) Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, et al. Journal article